Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)

This study is ongoing, but not recruiting participants.

Study NCT00736619 Information provided by Memorial Sloan-Kettering Cancer Center

First Received on August 15, 2008. Last Updated on January 31, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

HEAD & NECK Cancer

Additional conditions recognized in this trial

More general conditions related to this trial

Additional drug interventions recognized in this trial

Cetuximab
Paclitaxel

More general drug interventions related to this trial

Sponsors listed in this trial